Jennifer Jarrett - Chief Operating Officer, Arcus Biosciences, Inc

As of June 21, 2021


Jennifer Jarrett Net Worth

  • Net worth is estimated to be at least $4.54M
  • Owns at least 135,343 units of Arcus Biosciences, Inc stock
  • Sold an estimated value of $540.41K in the last 3 years at Arcus Biosciences, Inc

Jennifer Jarrett Compensation at Arcus Biosciences, Inc in 2020

  • Earned a $125,000 salary
  • Rewarded $10,578,439 in stock value and options
  • Received a total compensation of $10,896,760

Jennifer Jarrett Trading

  • Largest sale of shares was 8,661 units , worth over $303.39K on March 18, 2021
  • In total has made about 9 transactions over 3 years
  • Usually trades in June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jennifer Jarrett Mailing Address

  • Mailing address is C/o Medivation, Inc. 525 Market St., 36th Floor San Francisco CA 94105 CA

Arcus Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Terry Rosen, Ph.D. 2020 $325,625 - $2,351,475 $2,351,475 - $1,200 $5,683,300
Terry Rosen, Ph.D. 2019 $340,000 - $1,375,700 $1,375,700 - $1,200 $1,716,900
Jennifer Jarrett 2020 $125,000 - $10,578,439 $10,578,439 $75,000 $28,171 $10,896,760
William Grossman, M.D., Ph.D. 2020 $457,600 - $2,073,420 $2,073,420 $250,000 $1,200 $6,134,970
William Grossman, M.D., Ph.D. 2019 $296,667 $200,000 $2,723,040 $2,723,040 $180,000 $600 $3,400,307
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1724521/000156459021019630/rcus-def14a_20210603.htm

Arcus Biosciences, Inc Insider Trading

  • The most recent transaction was 2,915 units sold on June 21, 2021 by Carolyn Tang Attorney-In-Fact worth over $69.65K
  • In the last 3 years, insiders at Arcus Biosciences, Inc sold an estimated value of $1.38M and bought an estimated value of $227.36M
  • The most active traders are Terry Rosen, Chief Executive Officer,  Juan Jaen, President,  and William Grossman, Chief Medical Officer
  • Insider trading is most common in June, with the busiest year in 2021

Arcus Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1